Recruiting studies: High Risk Oral Precancerous Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796 Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06623110 Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
Phase N/A · 3 location(s) · Proteocyte Diagnostics Inc. · NCT04622462 Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
Phase 2 · 2 location(s) · University of Minnesota · NCT05727761 A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Phase 1 · 13 location(s) · BlossomHill Therapeutics · NCT06501196 A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706 Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™
Phase N/A · 5 location(s) · Proteocyte Diagnostics Inc. · NCT05853783

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.